The Power of Timely Treatment: Revolutionizing Anaphylaxis Treatment with Intranasal Epinephrine

home / sponsored-videos / the-power-of-timely-treatment-revolutionizing-anaphylaxis-treatment-with-intranasal-epinephrine

A panelist discusses how intranasal epinephrine could revolutionize anaphylaxis management by overcoming barriers such as needle anxiety, delayed administration, and underuse—especially in pediatric and high-risk groups—through its needle-free, user-friendly design, rapid and effective drug delivery, longer shelf life, and temperature stability; coupled with the critical importance of early epinephrine use, updated guidelines, and shared decision-making, this innovation promises to improve patient outcomes by enhancing accessibility, caregiver confidence, and adherence while addressing practical issues like cost and education.

The content of this program has been supported by ARS Pharmaceuticals

© 2025 MJH Life Sciences

All rights reserved.